Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche.

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche.

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi's novel stem cell-based ...

Sensei Biotherapeutics (SNSE) announced initial results from the dose expansion portion of its Phase 1/2 trial evaluating solnerstotug, a conditionally active monoclonal antibody targeting VISTA.

The actor who plays a villain on the ‘Yellowstone’ prequel series explains how his character’s “diabolical” mission led to a “dissent into madness” for the man who would never die ...

The 616 shareholders in attendance, who represented 77.03% of the total Roche Holding, Comcast, Eaton Corp and National Presto Industries are included in this Analyst Blog. Today's Research Daily ...

Local BBC Radio joins BBC Radio 5 live through the night on a weekday.